Heartbeam Inc (NASDAQ:BEAT) — Market Cap & Net Worth
Market Cap & Net Worth: Heartbeam Inc (BEAT)
Heartbeam Inc (NASDAQ:BEAT) has a market capitalization of $23.95 Million ($23.95 Million) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #24622 globally and #5268 in its home market, demonstrating a -0.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Heartbeam Inc's stock price $0.43 by its total outstanding shares 56349171 (56.35 Million). Also see BEAT asset base for a full breakdown of the balance sheet.
Heartbeam Inc Market Cap History: 2021 to 2026
Heartbeam Inc's market capitalization history from 2021 to 2026. Data shows change from $173.56 Million to $23.95 Million (-39.07% CAGR). Also see Heartbeam Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Index Memberships
Heartbeam Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #701 of 976 |
|
NASDAQ Composite
IXIC
|
$41.74 Trillion | 0.00% | #2301 of 3165 |
Weight: Heartbeam Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Heartbeam Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Heartbeam Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Heartbeam Inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BEAT by Market Capitalization
Companies near Heartbeam Inc in the global market cap rankings as of September 17, 2026. Review Heartbeam Inc tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Heartbeam Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #738 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1902 globally with a market cap of $12.23 Billion USD ( AU$17.28 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2076 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2133 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #738 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $266.62 |
| #1902 | Pro Medicus Ltd | AU:PME | $12.23 Billion | AU$165.45 |
| #2076 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $68.85 |
| #2133 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.84 |
Heartbeam Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Heartbeam Inc's market cap moved from $173.56 Million to $ 23.95 Million, with a yearly change of -39.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $23.95 Million | -82.29% |
| 2025 | $135.24 Million | +4.35% |
| 2024 | $129.60 Million | -2.13% |
| 2023 | $132.42 Million | -51.84% |
| 2022 | $274.98 Million | +58.44% |
| 2021 | $173.56 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Heartbeam Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $23.95 Million USD |
| MoneyControl | $23.95 Million USD |
| MarketWatch | $23.95 Million USD |
| marketcap.company | $23.95 Million USD |
| Reuters | $23.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection … Read more